Board Meeting Intimation for Results
Ortin Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 14, 2017, inter alia, to consider the following:1. Un-Audited financial results for the quarter ended December 31, 2016.2. Limited Review Report for the quarter ended December 31, 2016. Closure of Trading Window
Ortin Laboratories Ltd has informed BSE regarding "Closure of Trading Window". Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Ortin Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended December 31, 2016
Ortin Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here Standalone Financial Results, Limited Review Report for September 30, 2016
Ortin Laboratories Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 2016 Closure of Trading Window
Ortin Laboratories Ltd has informed BSE that the trading window in respect of the Company's Securities shall remain closed for all the Directors/Officers/Designed Employees of the Company from the trading hours on November 03, 2016 till close of the trading hours on November 14, 2016 as per the code of Internal Procedure and Conduct for Prevention of Insider Trading adopted by the Company for declaration of unaudited financial results for the quarter and half year ended September 30, 2016. Board Meeting Intimation for Results
Ortin Laboratories Ltd has informed BSE that the meeting of the Board of Directors of Company will be held on November 12, 2016, inter alia, to consider the following:1. Un - Audited financial results for the quarter ended September 30, 2016.2. Limited Review Report for the quarter ended September 30, 2016. Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Ortin Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended September 30, 2016
Ortin Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here Clarification
With reference to increase in Price, Ortin Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed.